GeoVax is a clinical-stage biotechnology company developing innovative human vaccines using our novel DNA/MVA platform technology.
Our proprietary vaccine technology has been developed through multi-year collaborations with the US National Institutes of Health, the US Centers for Disease Control and Prevention, and Emory University. Our mission is to apply our expertise in areas where there is a significant unmet medical need and commercial opportunity with the goal of improving the lives of people affected by serious and life-threatening diseases.
Our primary focus is to develop vaccines that prevent and fight Human Immunodeficiency Virus (HIV) infections and we have recently expanded our research and development efforts to include vaccines to prevent Ebola virus infection.
We know our work could affect the lives of millions worldwide, and we invite you to join our effort.